Clinical Trial Update: Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating maintenance niraparib in advanced urothelial cancer after first-line platinum-based chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: University of Turin, Italy | Conditions: Urothelial Carcinoma | Phase 2 | Status: COMPLETED